Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa and Tamoxifen in Inoperable Locally Advanced Breast Cancer
NCT00206492Phase 2Terminated
- Sponsor
- Baylor Breast Care Center
- Start
- Jul 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by Baylor Breast Care Center. Started Jul 2003; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00206492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206492.